JMP Securities Reiterates Market Outperform on Enanta Pharma, Lowers Price Target to $21

Benzinga · 5d ago
JMP Securities analyst Roy Buchanan reiterates Enanta Pharma (NASDAQ:ENTA) with a Market Outperform and lowers the price target from $22 to $21.